Consolidated Statement Of Cash Flows

Daito Pharmaceutical Co., Ltd. - Filing #7542348

Concept 2023-06-01 to
2023-08-31
2022-06-01 to
2022-08-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
1,092,000,000 JPY
1,470,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.